u 74389f has been researched along with Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corson, JD; Hoballah, JJ; Kresowik, TF; Mohan, CR; Sharp, WJ | 1 |
| Bahra, M; Hausen, B; Hewitt, CW; Morris, RE; Mueller, P; Ramsamooj, R | 1 |
2 other study(ies) available for u 74389f and Edema
| Article | Year |
|---|---|
Lazaroid U74389G attenuates skeletal muscle reperfusion injury in a canine model.
Topics: Analysis of Variance; Animals; Antioxidants; Dogs; Edema; In Vitro Techniques; Ischemia; Muscle, Skeletal; Necrosis; Peroxidase; Pregnatrienes; Reperfusion; Reperfusion Injury; Steroids, Heterocyclic; Thromboxane B2; Time Factors | 1995 |
Donor treatment with the lazeroid U74389G reduces ischemia-reperfusion injury in a rat lung transplant model.
Topics: Airway Resistance; Animals; Antioxidants; Disease Models, Animal; Edema; Ischemia; Lung; Lung Compliance; Lung Transplantation; Male; Organ Preservation; Organ Size; Oxygen; Pregnatrienes; Pulmonary Alveoli; Pulmonary Gas Exchange; Rats; Rats, Inbred Lew; Reperfusion; Reperfusion Injury; Survival Rate; Tissue Donors; Vascular Resistance; Weight Gain | 1997 |